Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
199.98
+0.32 (0.16%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Danaher Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 25,107 | 24,568 | 23,875 | 23,890 | 26,643 | 24,802 |
Revenue Growth | 4.56% | 2.90% | -0.06% | -10.33% | 7.42% | 11.30% |
Gross Profit Gross Profit Growth | 14,691 | 14,523 | 14,206 | 14,034 | 16,188 | 15,239 |
Operating Income Operating Income Growth | 5,127 | 4,690 | 4,863 | 5,202 | 7,536 | 6,377 |
Net Income Net Income Growth | 4,004 | 3,614 | 3,899 | 4,743 | 7,103 | 6,269 |
Earnings Per Share EPS Growth | 5.63 | 5.05 | 5.29 | 6.38 | 8.47 | 7.28 |
EPS Growth | 19.79% | -4.54% | -17.09% | -24.68% | 16.35% | 48.88% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biotechnology Biotechnology Growth | 7,548 | 7,293 | 6,759 | 7,172 | 8,758 | 8,570 |
Life Sciences Life Sciences Growth | 7,493 | 7,334 | 7,329 | 7,141 | 7,036 | 6,388 |
Diagnostics Diagnostics Growth | 10,066 | 9,941 | 9,787 | 9,577 | 10,849 | 9,844 |
Revenue (Total) Revenue (Total) Growth | 25,107 | 24,568 | 23,875 | 23,890 | 26,643 | 24,802 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 4,348 | 4,615 | 2,078 | 5,864 | 5,995 | 2,586 |
Total Debt Total Debt Growth | 26,558 | 18,418 | 16,005 | 18,402 | 19,677 | 22,176 |
Net Cash (Debt) Net Cash Growth | -22,210 | -13,803 | -13,927 | -12,538 | -13,682 | -19,590 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -31.24 | -19.28 | -18.89 | -16.87 | -18.56 | -26.59 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6,635 | 6,416 | 6,688 | 7,164 | 8,519 | 8,358 |
Capital Expenditures CapEx Growth | -1,169 | -1,156 | -1,392 | -1,383 | -1,118 | -1,240 |
Free Cash Flow Free Cash Flow Growth | 5,466 | 5,260 | 5,296 | 5,781 | 7,401 | 7,118 |
Free Cash Flow Growth | 12.42% | -0.68% | -8.39% | -21.89% | 3.98% | 31.40% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 58.51% | 59.11% | 59.50% | 58.74% | 60.76% | 61.44% |
Operating Margin | 20.42% | 19.09% | 20.37% | 21.77% | 28.29% | 25.71% |
Pretax Margin | 18.97% | 17.23% | 19.46% | 21.11% | 26.82% | 26.25% |
Profit Margin | 15.89% | 14.65% | 16.33% | 17.67% | 23.75% | 21.96% |
FCF Margin | 21.77% | 21.41% | 22.18% | 24.20% | 27.78% | 28.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.600 | 1.280 | 1.080 | 1.050 | 1.000 | 0.840 |
Dividend Per Share Growth | 22.03% | 18.52% | 2.86% | 5.00% | 19.05% | 16.67% |
Dividend Yield | 0.80% | 0.54% | 0.46% | 0.48% | 0.48% | 0.36% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 35.62 | 45.33 | 43.39 | 36.26 | 27.78 | 40.06 |
Forward PE | 22.60 | 28.24 | 28.68 | 31.08 | 26.58 | 33.25 |
P/FCF Ratio | 25.72 | 30.76 | 31.17 | 29.58 | 23.15 | 29.29 |
PS Ratio | 5.60 | 6.59 | 6.91 | 7.16 | 6.43 | 8.41 |